Q4 Earnings Roundup Ashok Leyland JSW Holdings Post Profit Growth Graphite India Reports Loss Japan Identified as Part of Fentanyl Smuggling Route by US Official Raising Economic and Security Concerns Bernstein Bullish on Indian Pharma Sees Up to 40 Upside in Six Stocks Sebi Chief Tuhin Kanta Pandey Advocates for Bond ETFs and Tokenisation as Corporate Debt Fundraising Approaches Rs 9 Lakh Crore OpenAIs Potential IPO Could Be Largest in History Challenging SpaceXs Lead Guzman y Gomez Exits US Market Amid Stiff Competition and Operational Challenges HBT Q1 2026 Earnings EPS Misses Estimates by 4481 as Net Income Falls Short BGSI Q1 2026 Earnings Earnings Slightly Miss Estimates as Stock Edges Lower Cousins Properties CUZ Q1 2026 Earnings EPS Beats Expectations Amid Stable Office Market CVBF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Interest Rate Environment InflaRx NV IFRX Q4 2025 Earnings Narrower Loss and Pipeline Progress Lift Sentiment MeiraGTx Holdings plc MGTX Q1 2026 Earnings WiderthanExpected Loss Amid Clinical Progress GTEC Holds Near Support After Marginal Gains Greenland Technologies in Focus Resolute Holdings Management RHLD Holds Steady Near 1145 Amid Consolidation AEFC Holds Steady Aegon Funding Subordinated Notes Remain Stable at 1917 UniFuels Holdings UFG Slips 318 as Stock Tests Key Support Near 067 NovaBay Pharmaceuticals NBY Jumps 226 as Trading Volume Surges LICs Valuation Cheap PE Masks Potential Expense Based on VNB Metrics FLD Q1 2026 Earnings Significant EPS Miss Sends Stock Lower Iveda Solutions Warrant IVDAW Holds Steady at 003 Amid Minimal Volatility Nyxoah NYXH Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Sleep Apnea Pipeline Schneider National Q1 2026 Earnings EPS Surpasses Expectations on Strong Cost Control IsoEnergy Q1 2026 Earnings Narrower Than Expected Loss as Uranium Developer Advances Projects Diversified Healthcare Trust 5625 Senior Notes due 2042 DHCNI Q1 2026 Earnings Deeper EPS Miss Signals Persistent Headwinds Skye Bioscience Q1 2026 Earnings Wider Loss Than Expected as DevelopmentStage Biotech Continues Cash Burn BJ Q1 2026 Earnings EPS Beat Fails to Lift Stock AEMD Q1 2026 Earnings NarrowerthanExpected Loss Boosts Investor Sentiment